What is the address of Arega Health?

The registered office of Arega Health is located at Stationsstraat 55, 2800 Mechelen.

Is Arega Health still active?

Yes. According to the CBE (29 October 2026) Arega Health is active, legal situation “Normale toestand”, started on 1 March 2019.

Is Arega Health registered on Peppol?

Yes, Arega Health is registered on the Peppol network with ID 0208:0721744435.

What is the enterprise number of Arega Health?

The enterprise number of Arega Health is BE0721744435.

When was Arega Health founded?

Arega Health was founded on 1 March 2019.

Who are the directors of Arega Health?

According to the 2025 annual accounts, the directors of Arega Health are: Thomson Management, Exscensus Beheer.

Is Arega Health a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 March 2019; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Arega Health make in 2025?

Arega Health posted a profit after taxes of € 4,027,600 in financial year 2025.

What is the revenue of Arega Health?

As a small company, Arega Health is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 5,763,405.

How many employees does Arega Health have?

According to the 2025 annual accounts, Arega Health has 0 full-time equivalents (FTE).

Arega Health (Private Limited) - Mechelen - BE0721744435

Q: What does Arega Health do?

Arega Health is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 1 March 2019, 1 establishment.

Dossier Arega Health, printed on 29 October 2026 from databakkes.be/en/0721744435/arega-health. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Arega Health from Mechelen, company number BE0721744435, closed financial year 2025 with a result of € 4 million after tax. For that financial year Arega Health recorded a gross margin of € 5.8 million and equity of € 10.5 million. Compared with financial year 2024, the result moved from € 3.2 million to € 4 million. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Growing

€ 10.5 million

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 4 million

▲ 24% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 7.4 million

▲ 153% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 3 million paid out

74 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 112,439

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 2.7 million

▼ 24% vs 2024

€ 666,667 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 18,927

▲ € 18,644 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1.5 million

▲ 19% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 3,799,708 Revenue 2022: € 3,799,708 First fiscal year in the series	€ 5,313,229 Revenue 2023: € 5,313,229 ▲ 40% vs 2022 (€ 3,799,708) Favourable step	€ 6,140,421 Revenue 2024: € 6,140,421 ▲ 16% vs 2023 (€ 5,313,229) Favourable step	-
Gross margin	€ 2,830,930 Gross margin 2022: € 2,830,930 First fiscal year in the series	€ 4,270,979 Gross margin 2023: € 4,270,979 ▲ 51% vs 2022 (€ 2,830,930) Favourable step	€ 5,299,058 Gross margin 2024: € 5,299,058 ▲ 24% vs 2023 (€ 4,270,979) Favourable step	€ 5,763,405 Gross margin 2025: € 5,763,405 ▲ 9% vs 2024 (€ 5,299,058) Favourable step	▲ 9%
Profit after taxes	€ 2,026,595 Profit after taxes 2022: € 2,026,595 First fiscal year in the series	€ 2,375,851 Profit after taxes 2023: € 2,375,851 ▲ 17% vs 2022 (€ 2,026,595) Favourable step	€ 3,238,731 Profit after taxes 2024: € 3,238,731 ▲ 36% vs 2023 (€ 2,375,851) Favourable step	€ 4,027,600 Profit after taxes 2025: € 4,027,600 ▲ 24% vs 2024 (€ 3,238,731) Favourable step	▲ 24%
Equity	€ 7,375,322 Equity 2022: € 7,375,322 First fiscal year in the series	€ 8,251,173 Equity 2023: € 8,251,173 ▲ 12% vs 2022 (€ 7,375,322) Favourable step	€ 9,489,904 Equity 2024: € 9,489,904 ▲ 15% vs 2023 (€ 8,251,173) Favourable step	€ 10,517,503 Equity 2025: € 10,517,503 ▲ 11% vs 2024 (€ 9,489,904) Favourable step	▲ 11%
Total debts	€ 4,724,984 Total debts 2022: € 4,724,984 First fiscal year in the series	€ 18,806,108 Total debts 2023: € 18,806,108 ▲ 298% vs 2022 (€ 4,724,984) Unfavourable step	€ 21,442,742 Total debts 2024: € 21,442,742 ▲ 14% vs 2023 (€ 18,806,108) Unfavourable step	€ 30,909,201 Total debts 2025: € 30,909,201 ▲ 44% vs 2024 (€ 21,442,742) Unfavourable step	▲ 44%
Cash	€ 1,313,445 Cash 2022: € 1,313,445 First fiscal year in the series	€ 6,350,328 Cash 2023: € 6,350,328 ▲ € 5 million vs 2022 (€ 1,313,445) Favourable step	€ 2,914,444 Cash 2024: € 2,914,444 ▼ 54% vs 2023 (€ 6,350,328) Unfavourable step	€ 7,384,934 Cash 2025: € 7,384,934 ▲ 153% vs 2024 (€ 2,914,444) Favourable step	▲ 153%
Retained profit	€ 7,355,322 Retained profit 2022: € 7,355,322 First fiscal year in the series	€ 8,231,173 Retained profit 2023: € 8,231,173 ▲ 12% vs 2022 (€ 7,355,322) Favourable step	€ 9,469,904 Retained profit 2024: € 9,469,904 ▲ 15% vs 2023 (€ 8,231,173) Favourable step	€ 10,497,503 Retained profit 2025: € 10,497,503 ▲ 11% vs 2024 (€ 9,469,904) Favourable step	▲ 11%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 1,500,000 Dividend 2023: € 1,500,000 Unchanged (€ 0) Unchanged	€ 2,000,000 Dividend 2024: € 2,000,000 ▲ 33% vs 2023 (€ 1,500,000) Unchanged	€ 3,000,000 Dividend 2025: € 3,000,000 ▲ 50% vs 2024 (€ 2,000,000) Unchanged	▲ 50%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 3,999,999 Bank debt 2023: € 3,999,999 Unchanged (€ 0) Unfavourable step	€ 3,526,250 Bank debt 2024: € 3,526,250 ▼ 12% vs 2023 (€ 3,999,999) Favourable step	€ 2,666,667 Bank debt 2025: € 2,666,667 ▼ 24% vs 2024 (€ 3,526,250) Favourable step	▼ 24%
Balance sheet total	€ 12,100,306 Balance sheet total 2022: € 12,100,306 First fiscal year in the series	€ 27,057,281 Balance sheet total 2023: € 27,057,281 ▲ 124% vs 2022 (€ 12,100,306) Unchanged	€ 30,932,646 Balance sheet total 2024: € 30,932,646 ▲ 14% vs 2023 (€ 27,057,281) Unchanged	€ 41,426,704 Balance sheet total 2025: € 41,426,704 ▲ 34% vs 2024 (€ 30,932,646) Unchanged	▲ 34%

Key figures of Arega Health, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Arega Health?

What happened at Arega Health in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 30, 2026 New annual accounts for financial year 2025: profit of € 4 million (▲ 24% vs 2024). Source: NBB ↗
Mar 1, 2019 New establishment in Mechelen. KBO
Mar 1, 2019 Start of the company according to the CBE. KBO

In short

From € 2 million profit in 2022 to € 4 million profit in 2025.

Paid € 4.2 million in corporate taxes since 2022.

Best year ever: 2025, with € 4 million profit.

Paid out € 6.5 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Thomson Management

Exscensus Beheer

Arega Health

Arega Pharma 100%

Behind Arega Health are Thomson Management and Exscensus Beheer. It owns 100% of Arega Pharma itself.

Directors

According to the 2025 annual accounts

Thomson Management

Director · represented by Mark Thomson

Exscensus Beheer

Director · represented by Hendrik Grooters

Establishments

Establishment units

Physical locations of this company

Registered office

Stationsstraat 55

2800 Mechelen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 9 companies are registered at this address.

All companies at this address →

ALCON

€ 50.9 million revenue · 2025

Protostars

Spectricity

€ 118,664 revenue · 2025

Arega Pharma same network

€ 63.4 million revenue · 2025

Let's App

€ -1.4 million gross margin · 2025

+4 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0721.744.435

VAT number

BE 0721.744.435

Registered office

Stationsstraat 55, 2800 Mechelen

Names & denominations

Arega Health

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 March 2019

Peppol

Active · Active since 29 Dec 2025

Contact

[email protected]

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Overige financiële dienstverlening, neg

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

Arega Health

Financials

What happened to Arega Health?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions